Accelerate Diagnostics Income Statement - Quarterly (NASDAQ:AXDX)

Add to My Stocks
$21.85 $0.8 (3.53%) AXDX stock closing price Jan 17, 2017 (Closing)

AXDX stock valuation based on fundamental analysis involves checking and analyzing financial statements and not just the Accelerate Diagnostics stock price. The income statement is a summary of the revenue, expenses and profitability (shown as Net Income) or lack of it. Investors typically check YoY or QoQ revenue growth. The operating expenses (also check: Accelerate Diagnostics assets and Accelerate Diagnostics free cash flow) as shown in the Accelerate Diagnostics profit and loss statement 2016-Q3 total to $17.43M. This line item has decreased from $17.89M compared with last quarter. View details of revenue and profits for Accelerate Diagnostics for latest & last 40 quarters.

show more
Annual
Quarterly
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec. 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2
Accelerate Diagnostics Net Sales or Revenues
0.02M0.02M0.16M0.02M0.09M0.02M0.01M0.08M0.02M0.01M
Cost Of Goods Sold (COGS)----------
Accelerate Diagnostics Gross Profit
0.02M0.02M0.16M0.03M0.09M0.01M0.01M0.09M0.01M0.01M
Research & Development Expense7.53M8.06M7.35M6.04M6.49M7.12M6.37M5.99M5.94M4.56M
Selling General & Admin Expense9.3M9.23M7.43M5.94M4.33M4.75M2.86M2.59M2.62M3.44M
Income Before Depreciation Depletion Amortization-16.81M-17.28M-14.62M-11.93M-10.73M-11.86M-9.23M-8.49M-8.55M-7.99M
Depreciation Depletion Amortization0.6M0.6M0.54M0.61M0.46M0.4M0.32M0.32M0.26M0.16M
Non Operating Income0.11M0.02M0.09M0.03M0.02M0.01M0.01M0.03M0.01M0.01M
Interest Expense---0.02M---0.01M--
Accelerate Diagnostics Pretax Income
-17.29M-17.86M-15.07M-12.52M-11.18M-12.25M-9.54M-8.78M-8.81M-8.15M
Provision for Income Taxes---0.64M---0.64M---
Minority Interest----------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations-17.3M-17.87M-15.07M-13.16M-11.82M-12.25M-8.9M-8.77M-8.81M-8.15M
Extraordinary Items & Discontinued Operations----------
Accelerate Diagnostics Net Income (Profit/Loss)
-17.3M-17.87M-15.07M-13.16M-11.82M-12.25M-8.9M-8.77M-8.81M-8.15M
Average Shares used to compute Diluted EPS51.24M51.21M51.2M45M44.73M44.68M44.65M43.83M44.58M43.48M
Average Shares used to compute Basic EPS51.24M51.21M51.2M45M44.73M44.68M44.65M43.83M44.58M43.48M
Income Before Nonrecurring Items-17.3M-17.87M-15.07M-13.16M-11.82M-12.25M-8.9M-8.77M-8.81M-8.15M
Income from Nonrecurring Items----------
Accelerate Diagnostics Earnings Per Share Basic Net
-0.34-0.35-0.29-0.29-0.25-0.27-0.20-0.20-0.20-0.19
Accelerate Diagnostics Earnings Per Share Diluted Net
-0.34-0.35-0.29-0.29-0.25-0.27-0.20-0.20-0.20-0.19
EPS Diluted Before Nonrecurring Items-0.34-0.35-0.29-0.29-0.25-0.27-0.20-0.20-0.20-0.19
Preferred Dividends Acc Pd----------
Dividends Common----------
Dividend Per Share Common----------
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters
Get Income statement for another ticker

1:25
AXDX
Before investing one should read a report on Accelerate Diagnostics stock analysis. It helps to look at the following income statement items:
  • Revenue: The money received by selling of goods or services comes under this line item. A QoQ growth (See: Accelerate Diagnostics revenue chart) implies that the company is growing, which has been the case with Accelerate Diagnostics. One must stay away from stocks whose revenues are declining.
  • Bottom line: This refers to the last line in a profit and loss statement and denotes the net profit or loss for a particular period. The figure currently stands at $-17.3M for Accelerate Diagnostics for 2016-Q3. This figure is arrived at after deducting all operating expenses, interest, and taxes from revenue.
The income statement is also called the profit and loss statement. Apart from the income statement, one can check the Accelerate Diagnostics historical stock prices to check how the price has moved with time. .

Accelerate Diagnostics Income Statement - Key Financial Ratios

PS ratio (
price sales ratio
)
5089.0636
Operating margin
-87050
Net profit margin
-86500
Dividend yield
0%